Safeguard Scientifics, Inc. New (SFE): Price and Financial Metrics

Safeguard Scientifics, Inc. New (SFE): $7.72

-0.16 (-2.03%)

POWR Rating

Component Grades













Add SFE to Watchlist
Sign Up

Industry: Private Equity


of 39

in industry

SFE Stock Price Chart Interactive Chart >

Price chart for SFE

SFE Price/Volume Stats

Current price $7.72 52-week high $8.78
Prev. close $7.88 52-week low $4.43
Day low $7.52 Volume 179,800
Day high $7.98 Avg. volume 107,064
50-day MA $7.05 Dividend yield N/A
200-day MA $6.44 Market Cap 161.29M

Safeguard Scientifics, Inc. New (SFE) Company Bio

Safeguard Scientifics is a private equity and venture capital firm specializing in expansion financings, growth capital, management buyouts, recapitalizations, industry consolidations, corporate spinouts, growth stage, and early stage financings. The company was founded in 1953 and is based in Wayne, Pennsylvania.

SFE Latest News Stream

Event/Time News Detail
Loading, please wait...

SFE Latest Social Stream

Loading social stream, please wait...

View Full SFE Social Stream

Latest SFE News From Around the Web

Below are the latest news stories about Safeguard Scientifics Inc that investors may wish to consider to help them evaluate SFE as an investment opportunity.

Safeguard Scientifics reports Q4 results

Safeguard Scientifics (SFE): Q4 GAAP EPS of -$0.35.Cash and cash equivalents of $15.6MPress Release...

Seeking Alpha | March 4, 2021

Safeguard Scientifics To Release Fourth Quarter And Full Year Financial Results On Thursday, March 4th

Safeguard Scientifics, Inc. (NYSE:SFE) will release its financial results for the fourth quarter and full year ended December 31, 2020 prior to market open on Thursday, March 4, 2021.

Yahoo | February 24, 2021

Safeguard Scientifics To Host A Virtual Discussion With Prognos Health

RADNOR, Pa. , Feb. 11, 2021 /PRNewswire/ -- Safeguard Scientifics, Inc. (NYSE: SFE ) ("Safeguard" or the "Company") announced that it will host a virtual discussion with Sundeep Bhan, CEO of Prognos Health at 10:00 a.m. ET on Tuesday, February 23, 2021. In a continued effort to provide shareholders with additional information about Safeguard's ownership interests, Dr. Gary Kurtzman will lead a discussion with Mr. Bhan about Prognos Health. Safeguard first provided capital to Prognos in 2011 and has participated in multiple follow-on funding rounds aggregating to $12.6 million of funded capital and a 28% ownership interest. Mr. Bhan is a serial entrepreneur dedicated to improving health using technology. He is currently the CEO and Co-founder of Prognos Health, a leading healthcare platf...

Benzinga | February 11, 2021

Safeguard Scientifics Inc (SFE) Q3 2020 Earnings Call Transcript

Good morning, and thank you for joining us for this update on Safeguard Scientifics' third quarter 2020 financial results. Joining me on today's call and webcast are Robert Rosenthal, Safeguard's Executive Chairman of the Board; Eric Salzman, Safeguard's Chief Restructuring Officer; and Mark Herndon, Safeguard's Chief Financial Officer.

Yahoo | November 6, 2020

Safeguard Scientifics Announces Third Quarter 2020 Financial Results

Safeguard Scientifics, Inc. (NYSE: SFE) ("Safeguard" or the "Company") today announced financial results for the three months and nine months ended September 30, 2020.

Yahoo | November 5, 2020

Read More 'SFE' Stories Here

SFE Price Returns

1-mo -4.22%
3-mo 15.74%
6-mo 28.03%
1-year -12.37%
3-year -39.92%
5-year -35.07%
YTD 21.00%
2020 -41.89%
2019 27.38%
2018 -23.04%
2017 -16.73%
2016 -7.31%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 1.043 seconds.